ChemT Biotechnology
Develops AI virtual cell platform to optimize biomanufacturing processes for biopharma companies
$4MSeed
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops AI virtual cell platform to optimize biomanufacturing processes for biopharma companies
Develops AI-enabled multifunctional biologics platform targeting cardiometabolic, oncology, and autoimmune diseases
Pitching SEEDS? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room